A 65-year-old man with oligometastatic prostate cancer underwent radical prostatectomy and stereotactic body radiation therapy (SBRT) to a right pubic bone metastasis. Four weeks after SBRT, PSMA PET showed increased extent and intensity of uptake at the treated site, despite a 92% PSA decline (8.5 to 0.7 ng/mL) and no new lesions. Later imaging confirmed resolution of uptake, consistent with bone flare, but revealed multiple new osseous metastases and rising PSA (2.8 ng/mL), indicating progression. To our knowledge, this is the first reported case of SBRT-induced bone flare, highlighting the need for cautious interpretation of early posttreatment PSMA PET.
Building similarity graph...
Analyzing shared references across papers
Loading...
Valentina Marulanda-Corzo
Preeti Kakkar
Arman Sharbatdaran
Clinical Nuclear Medicine
Cornell University
Presbyterian Hospital
Lander Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Marulanda-Corzo et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d8967d6c1944d70ce07e8c — DOI: https://doi.org/10.1097/rlu.0000000000006447
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: